USA |NASDAQ |USD
| Report Date | Period Ending | EPS Forecast | Last Quarter's EPS | Last Year's EPS |
|---|---|---|---|---|
| Nov 10, 2021 | Sep 2021 | $-1.16 | $-0.99 | $-1.33 |
| Report Date | Period Ending | Revenue Forecast | Last Quarter’s Revenue | Last Year’s Revenue |
|---|---|---|---|---|
| Nov 10, 2021 | Sep 2021 | $0.00 | $0.00 | $0.00 |
Applied Therapeutics's next earnings date is Wednesday, Nov 10, 2021 for the fiscal quarter ending Sep 2021.
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 7 | $-1.22 | $-1.37 | $-0.99 |
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 7 | $-4.41 | $-4.62 | $-3.96 |
| Dec 2022 | 7 | $-4.30 | $-5.09 | $-3.21 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Dec 2021 | 1 / 0 | $-1.21 | $-1.34 | $-1.34 |
| Period End | Up/Down 1M | 1M Trend | 2M Trend | 3M Trend |
|---|---|---|---|---|
| Dec 2021 | 2 / 0 | $-4.37 | $-4.84 | $-4.84 |
| Dec 2022 | 0 / 0 | $-4.30 | $-4.87 | $-4.87 |
| Period End | # of Analysts | Revenue Forecast | Low Revenue Forecast | High Revenue Forecast |
|---|---|---|---|---|
| Dec 2021 | 4 | $0.00 | $0.00 | $0.00 |
| Period End | # of Analysts | EPS Forecast | Low EPS Forecast | High EPS Forecast |
|---|---|---|---|---|
| Dec 2021 | 5 | $0.00 | $0.00 | $0.00 |
| Dec 2022 | 7 | $5.34M | $820.00K | $14.50M |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Nov 10, 2021 | Sep 2021 | $-1.16 | - | - |
| Aug 12, 2021 | Jun 2021 | $-1.17 | $-0.99 | 15.38% |
| May 11, 2021 | Mar 2021 | $-1.00 | $-1.00 | 0.02% |
| Mar 18, 2021 | Dec 2020 | $-1.16 | $-1.06 | 8.66% |
| Nov 12, 2020 | Sep 2020 | $-0.89 | $-1.33 | -48.99% |
| Aug 11, 2020 | Jun 2020 | $-0.68 | $-1.27 | -85.75% |
| May 11, 2020 | Mar 2020 | $-0.84 | $-0.59 | 29.48% |
| Mar 13, 2020 | Dec 2019 | $-0.64 | $-1.57 | -145.73% |
| Nov 13, 2019 | Sep 2019 | $-0.44 | $-0.63 | -42.63% |
| Aug 12, 2019 | Jun 2019 | $-0.43 | $-0.60 | -39.89% |
| Jun 21, 2019 | Mar 2019 | $-0.39 | $-0.67 | -71.79% |
| Report Date | Period Ending | Forecast EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| Mar 18, 2021 | Dec 2020 | $-4.53 | $-4.25 | - |
| Mar 13, 2020 | Dec 2019 | $-3.00 | $-3.47 | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Nov 10, 2021 | Sep 2021 | $0.00 | - | - |
| Aug 12, 2021 | Jun 2021 | $0.00 | $0.00 | - |
| May 11, 2021 | Mar 2021 | $0.00 | $0.00 | - |
| Mar 18, 2021 | Dec 2020 | $0.00 | $0.00 | - |
| Nov 12, 2020 | Sep 2020 | $0.00 | $0.00 | - |
| Aug 11, 2020 | Jun 2020 | $0.00 | $0.00 | - |
| May 11, 2020 | Mar 2020 | $0.00 | $0.00 | - |
| Mar 13, 2020 | Dec 2019 | $0.00 | $0.00 | - |
| Nov 13, 2019 | Sep 2019 | $0.00 | $0.00 | - |
| Aug 12, 2019 | Jun 2019 | $0.00 | $0.00 | - |
| Jun 21, 2019 | Mar 2019 | $0.00 | $0.00 | - |
| Report Date | Period Ending | Forecast Revenue | Actual Revenue | Surprise |
|---|---|---|---|---|
| Mar 18, 2021 | Dec 2020 | $0.00 | $0.00 | - |
| Mar 13, 2020 | Dec 2019 | $0.00 | $0.00 | - |
APLT's next earnings date is Wednesday, Nov 10, 2021 for the fiscal quarter ending Sep 30, 2021.
According to 7 analysts, the average EPS estimation for Applied Therapeutics's next quarterly earnings is $-1.16, with a low EPS estimation of $-1.34, and a high estimation of $-0.99.
Over the last 1 month, EPS estimates have seen 2 upward revisions and 0 downward. The EPS 1 month trend is $-1.17, the last 2 month trend is $-1.25, and the 3 month trend is $-1.25.
Based on 4 analysts, the average revenue estimation is $0.00, with a low revenue estimation of $0.00, and a high estimation of $0.00.
Applied Therapeutics's previous earnings date was Aug 12, 2021 for its fiscal quarter ended Jun 30, 2021.
APLT's earnings per share (EPS) was $-0.99, beating the consensus analysts forecast of $-1.17 by 15.38%.
The EPS was higher than the previous fiscal quarter (Mar 2021) by -1.00%, and higher than the same period a year before (Jun 2020) by -22.05%.
Revenues were $0.00.
The company reported a net income of $-25.83M.Free cash flow for the quarter was $-25.91M , compared to $-22.21M last quarter and $-15.91M a year before.
APLT ended the quarter with $4.70M in total debt, an increase of 186.64% compared to the previous quarter, and a decrease of -7.63% compared to the same quarter a year before.
Applied Therapeutics's previous annual earnings date was Mar 18, 2021 for its fiscal year ended Dec 31, 2020.
APLT's earnings per share (EPS) was $-4.25, beating the consensus analysts forecast of $-4.53 by -6.18% , and lower than the previous year's EPS (Dec 2019) by 22.48%.
Revenues were $0.00.
The company reported a net income of $-93.96M.
Applied Therapeutics reported a free cash flow of $-78.21M for its fiscal year, compared to $-36.31M a year ago.
The company ended the fiscal year with $2.81M in total debt, an increase of 37.91% compared to the previous year.
Get a weekly snapshot of one new investment idea from stock exchanges worldwide.